PharmaEngine, Inc. (TPEX:4162)
Taiwan
· Delayed Price · Currency is TWD 72.60
-0.50 (-0.68%)
At close: Dec 5, 2025
PharmaEngine Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 1,675 | 1,751 | 274.65 | 318.78 | 426.03 | 604.28 | Upgrade
|
| Depreciation & Amortization | 9.8 | 9.31 | 9.02 | 8.61 | 10.26 | 12.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -5.53 | -45.46 | -0.83 | - | Upgrade
|
| Stock-Based Compensation | 0.52 | 1.3 | 3.38 | 2.37 | 0.09 | -1.06 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | 0 | -0 | 0.01 | -0.22 | - | Upgrade
|
| Other Operating Activities | 49.03 | 344.77 | -33.31 | -54.79 | -81.69 | 69.67 | Upgrade
|
| Change in Accounts Receivable | -16.38 | -1,670 | -13.83 | 0.13 | 541.22 | -616.82 | Upgrade
|
| Change in Inventory | -13.35 | -12.48 | 18.47 | -28.94 | 19.31 | -0.62 | Upgrade
|
| Change in Accounts Payable | - | - | - | -2.05 | 8.62 | 12.06 | Upgrade
|
| Change in Other Net Operating Assets | 15.15 | 32.89 | 4.12 | 3.36 | 6.87 | -15.3 | Upgrade
|
| Operating Cash Flow | 1,720 | 456.73 | 256.97 | 202.01 | 929.67 | 64.77 | Upgrade
|
| Operating Cash Flow Growth | 318.51% | 77.74% | 27.21% | -78.27% | 1335.36% | 302.84% | Upgrade
|
| Capital Expenditures | -0.39 | -0.81 | -0.41 | -3.44 | -0.23 | - | Upgrade
|
| Sale (Purchase) of Intangibles | 0 | -0.6 | - | -0.5 | - | -0.61 | Upgrade
|
| Investment in Securities | -55.12 | -114.67 | -854.48 | -183.98 | -105 | 1,765 | Upgrade
|
| Other Investing Activities | -0 | 0.55 | -0.59 | -0.2 | -1.77 | -0.07 | Upgrade
|
| Investing Cash Flow | -55.51 | -115.54 | -855.48 | -188.12 | -107 | 1,764 | Upgrade
|
| Long-Term Debt Repaid | - | -7.67 | -7.54 | -8 | -9.6 | -10.82 | Upgrade
|
| Net Debt Issued (Repaid) | -8.2 | -7.67 | -7.54 | -8 | -9.6 | -10.82 | Upgrade
|
| Repurchase of Common Stock | - | - | - | - | -133.41 | -3.84 | Upgrade
|
| Common Dividends Paid | -861.92 | -215.44 | -287.19 | -387.71 | -363.99 | -72.83 | Upgrade
|
| Financing Cash Flow | -870.13 | -223.11 | -294.73 | -395.71 | -507 | -87.5 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.75 | 1.56 | Upgrade
|
| Net Cash Flow | 793.97 | 118.08 | -893.24 | -381.81 | 314.93 | 1,743 | Upgrade
|
| Free Cash Flow | 1,719 | 455.92 | 256.56 | 198.57 | 929.44 | 64.77 | Upgrade
|
| Free Cash Flow Growth | 319.34% | 77.71% | 29.20% | -78.64% | 1335.01% | 308.12% | Upgrade
|
| Free Cash Flow Margin | 68.63% | 18.07% | 33.42% | 30.34% | 141.94% | 6.13% | Upgrade
|
| Free Cash Flow Per Share | 11.94 | 3.17 | 1.78 | 1.38 | 6.42 | 0.44 | Upgrade
|
| Cash Interest Paid | 0.1 | 0.18 | 0.31 | 0.08 | 0.21 | 0.44 | Upgrade
|
| Cash Income Tax Paid | 392.14 | 61.37 | 92.35 | 124.42 | 200.65 | 99.35 | Upgrade
|
| Levered Free Cash Flow | 1,317 | -19.65 | 159.87 | 105.29 | 723.9 | -50.51 | Upgrade
|
| Unlevered Free Cash Flow | 1,317 | -19.54 | 160.06 | 105.34 | 724.04 | -50.23 | Upgrade
|
| Change in Working Capital | -14.57 | -1,650 | 8.76 | -27.51 | 576.02 | -620.68 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.